Search Results - "subgroup"
Suggested Topics within your search.
Suggested Topics within your search.
- Medicine 9
- Research & information: general 9
- linguistics 8
- Biology, life sciences 6
- Mathematics 4
- Bilingual & multilingual dictionaries 3
- Dictionaries 3
- Educational psychology 3
- Food & society 3
- History of engineering & technology 3
- Neurosciences 3
- Oncology 3
- Agronomy & crop production 2
- Asian history 2
- Botany & plant sciences 2
- Education 2
- Examinations & assessment 2
- Hepatology 2
- Historical & comparative linguistics 2
- Language and languages 2
- Language: history & general works 2
- Mathematics & science 2
- Migration, immigration & emigration 2
- Pest control 2
- Philosophy 2
- Physics 2
- Social research & statistics 2
- Sustainable agriculture 2
- Technology: general issues 2
- Usage & grammar guides 2
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
-
210
-
211
-
212
-
213
Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients
Published 2020Connect to this object online.
Book -
214
-
215
-
216
The taxonomy of "digital health interventions" and their subgroups in the therapeutic rehabilitation of stroke patients - A scoping review / Die Taxonomie der "digitalen Gesundheitsinterventionen" und ihrer Untergruppen in der therapeutischen Schlaganfallrehabilitation - Ein Scoping Review
Published 2023Connect to this object online.
Book -
217
-
218
-
219
Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial
Published 2023Connect to this object online.
Book -
220
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors
Published 2023Connect to this object online.
Book